Aleta Biotherapeutics

Redirection and Restoration of CAR-T Therapy

Aleta Biotherapeutics is an immuno-oncology company transforming cell therapies to target a wide range of cancer indications, including currently untreatable solid tumors.

CEO
Paul Rennert

WEBSITE
http://www.aletabio.com/

INVESTED COMPANY
2021

DETAILS
Aleta Biotherapeutics
27 Strathmore Rd.
Natick, MA USA 01760

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.